Overview
Yu Liu practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, Late-Onset Retinal Degeneration, and Usher Syndrome.
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yu Liu
Is Yu Liu a top-rated expert for Retinitis Pigmentosa?
MediFind is an objective health platform that identifies experts based on real-world data. Yu Liu is classified as an Experienced expert for Retinitis Pigmentosa, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yu Liu participate in research or clinical trials?
Yes. Yu Liu has published 14 articles and abstracts on conditions like Retinitis Pigmentosa. You can view a list of Yu Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Hearing LossLiu isExperienced. Learn about Hearing Loss.
- Late-Onset Retinal Degeneration
- Retinitis PigmentosaLiu isExperienced. Learn about Retinitis Pigmentosa.
- Retinopathy Pigmentary Mental Retardation
- Usher SyndromeLiu isExperienced. Learn about Usher Syndrome.